Stay updated with breaking news from Teva Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva Pharmaceutical Industries Ltd. today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and...
TEL AVIV, Israel & PARSIPPANY, N.J., September 28, 2023--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and Christine (Chris) Fox, who most recently served as Global President, Gene Therapies at Novartis will be the new head of Teva’s U.S. Commercial Business. "On behalf of the Teva Board of Directors and our executive management team
Teva Announces Appointment of Richard Francis as President and CEO - read this article along with other careers information, tips and advice on BioSpace